Looking to list your PhD opportunities? Log in here.
About the Project
Our research group is focused on understanding the molecular mechanisms underlying the development and progression of heart failure and in doing so identifying potential new targets for its treatment. Heart failure (HF) currently affects around 1 million people in the UK leading to an annual financial burden on the health services of over £1 billion, and its incidence is rising rapidly. HF has a dismal prognosis, with patients dying from progressive pump failure or ventricular arrhythmias. Hypertension, which affects around 15% of the general population, is strongly associated with heart failure with 80% of HF patients having hypertension.
Over the past few years it has become clear that PMCA1, a calcium transporter which ejects calcium from the cell, is involved in all of the central features of heart failure. Human genome wide association studies have shown a link between PMCA1 and hypertension, which is a common underlying cause for HF as well as with coronary artery disease and myocardial infarction. Our own studies have provided functional evidence of the role of PMCA1 in the development of cardiomyopathy, myocardial infarction, arrhythmias and hypertension.
This PhD project will explore and characterise the mechanisms underlying the key role PMCA1 plays in the diseased cardiovascular system.
Entry Requirements
Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in a biomedical, physiology, pharmacology or related area / subject and preferably a master degree.
How To Apply
For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the appropriate subject title.
For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences.
Equality, Diversity and Inclusion
Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/”
Funding Notes
References
Little, R., Zi, M., Hammad, S.K., Nguyen, L., Njegic, A., Kurusamy, S., Prehar, S., Armesilla, A.L., Neyses, L., Austin, C., Cartwright, E.J. (2017). Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries. Aging Cell 16, 1104-1113.
Mohamed, T.M. A., Abou-Leisa, R., Stafford, N., Maqsood, A., Zi, M., Prehar, S., Baudoin-Stanley, F., Wang, X., Neyses, L., Cartwright, E.J., Oceandy, D. (2016). The plasma membrane calcium ATPase 4 signaling in cardiac fibroblasts mediates cardiomyocyte hypertrophy.
Email Now
Why not add a message here
The information you submit to The University of Manchester will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Manchester, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Understanding how p18/LAMTOR1 maintains the pulmonary endothelium – a potential therapeutic target for chronic respiratory diseases
Anglia Ruskin University ARU
Impact of cardiac resynchronisation therapy on cerebrovascular health and functional implications for cognitive and biomechanical performance in heart failure patients with and without atrial fibrillation
Manchester Metropolitan University
Better diagnosis and intervention for sarcopenia and frailty, and multimorbidity (cardiovascular disease, heart failure, Chronic obstructive pulmonary disease (COPD)) utilizing metabolomic.
University of Liverpool